Avanos Medical, Inc.
US ˙ NYSE ˙ US05350V1061

SecurityAVNS / Avanos Medical, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership2,157,531 shares
Ownership 4.60%
Dimensional Fund Advisors Lp ownership in AVNS / Avanos Medical, Inc.

2026-01-21 - Dimensional Fund Advisors Lp has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,157,531 shares of Avanos Medical, Inc. (US:AVNS). This represents 4.6 percent ownership of the company. In their previous filing dated 2025-10-09 , Dimensional Fund Advisors Lp had reported owning 2,352,634 shares, indicating a decrease of -8.29 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-01-21 2026-01-21 13G/A 2,352,634 2,157,531 -8.29 4.60 -9.80
2025-10-09 2025-10-09 13G/A 2,854,235 2,352,634 -17.57 5.10 -16.39
2024-02-09 2024-02-09 13G/A 2,891,836 2,854,235 -1.30 6.10 -1.61
2023-02-10 2023-02-10 13G 2,289,799 2,891,836 26.29 6.20 29.71
2020-02-12 2020-02-12 13G/A 2,832,455 2,289,799 -19.16 4.78 -19.93
2019-02-08 2019-02-08 13G/A 2,832,455 5.97
2018-02-09 2018-02-09 13G 3,380,363 7.22

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F AVANOS MED COM 05350V106 2,052,356 -105,175 -4.87 28,753 18.67 0.0060
2026-02-12 2025-12-31 13F AVANOS MED COM 05350V106 2,157,531 -195,103 -8.29 24,229 -10.91 0.0051
2025-11-12 2025-09-30 13F AVANOS MED COM 05350V106 2,352,634 -225,430 -8.74 27,196 -13.81 0.0058
2025-08-12 2025-06-30 13F AVANOS MED COM 05350V106 2,578,064 -17,289 -0.67 31,556 -15.15 0.0073
2025-05-13 2025-03-31 13F AVANOS MED COM 05350V106 2,595,353 17,036 0.66 37,190 -9.39 0.0092
2025-02-13 2024-12-31 13F AVANOS MED COM 05350V106 2,578,317 -11,668 -0.45 41,046 -34.05 0.0099
2024-11-07 2024-09-30 13F AVANOS MED COM 05350V106 2,589,985 12,350 0.48 62,236 21.21 0.0151
2024-08-09 2024-06-30 13F AVANOS MED COM 05350V106 2,577,635 -102,681 -3.83 51,346 -3.79 0.0134
2024-05-10 2024-03-31 13F AVANOS MED COM 05350V106 2,680,316 -173,919 -6.09 53,365 -16.64 0.0144
2024-02-07 2023-12-31 13F AVANOS MED COM 05350V106 2,854,235 -55,750 -1.92 64,021 8.81 0.0187
2023-11-09 2023-09-30 13F AVANOS MED COM 05350V106 2,909,985 -208,167 -6.68 58,841 -26.17 0.0193
2023-08-09 2023-06-30 13F AVANOS MED COM 05350V106 3,118,152 -55,642 -1.75 79,700 -15.56 0.0254
2023-05-12 2023-03-31 13F AVANOS MED COM 05350V106 3,173,794 281,958 9.75 94,387 120,907.69 0.0318
2023-02-09 2022-12-31 13F AVANOS MED COM 05350V106 2,891,836 64,029 2.26 78 -99.87 0.0231
2022-11-10 2022-09-30 13F AVANOS MED COM 05350V106 2,827,807 188,035 7.12 61,590 -14.66 0.0236
2022-08-12 2022-06-30 13F AVANOS MED COM 05350V106 2,639,772 273,823 11.57 72,171 -8.94 0.0259
2022-05-13 2022-03-31 13F AVANOS MED COM 05350V106 2,365,949 271,105 12.94 79,260 9.13 0.0244
2022-02-09 2021-12-31 13F AVANOS MED COM 05350V106 2,094,844 -76,655 -3.53 72,628 7.20 0.0220
2021-11-12 2021-09-30 13F AVANOS MED COM 05350V106 2,171,499 -209,594 -8.80 67,752 -21.77 0.0218
2021-08-12 2021-06-30 13F AVANOS MED COM 05350V106 2,381,093 111,696 4.92 86,602 -12.76 0.0274
2021-05-14 2021-03-31 13F AVANOS MED COM 05350V106 2,269,397 57,263 2.59 99,263 -2.20 0.0328
2021-03-08 2020-12-31 13F/A-2 AVANOS MED COM 05350V106 2,212,134 5,442 0.25 101,493 38.45 0.0366
2021-02-11 2020-12-31 13F AVANOS MED COM 05350V106 2,212,134 5,442 101,493 36,653.8770
2020-11-12 2020-09-30 13F AVANOS MED COM 05350V106 2,206,692 23,833 1.09 73,305 14.27 0.0311
2020-08-13 2020-06-30 13F AVANOS MED COM 05350V106 2,182,859 -175,307 -7.43 64,153 1.02 0.0282
2020-05-14 2020-03-31 13F AVANOS MED COM 05350V106 2,358,166 68,367 2.99 63,505 -17.70 0.0331
2020-02-14 2019-12-31 13F AVANOS MED COM 05350V106 2,289,799 7,992 0.35 77,166 -9.72 0.0281
2019-11-12 2019-09-30 13F AVANOS MED COM 05350V106 2,281,807 67,451 3.05 85,477 -11.49 0.0332
2019-08-13 2019-06-30 13F AVANOS MED COM 05350V106 2,214,356 -175,831 -7.36 96,569 -5.33 0.0375
2019-08-12 2019-03-31 13F/A-2 AVANOS MED COM 05350V106 2,390,187 -442,268 -15.61 102,011 -19.59 0.0406
2019-05-10 2019-03-31 13F AVANOS MED COM 05350V106 2,390,187 -442,268 102,011
2019-02-26 2018-12-31 13F/A-1 AVANOS MED COM 05350V106 2,832,455 -286,879 -9.20 126,863 -40.63 0.0575
2019-02-13 2018-12-31 13F AVANOS MED COM 05350V106 2,832,455 -286,879 126,863
2018-11-13 2018-09-30 13F AVANOS MED COM 05350V106 3,119,334 -127,366 -3.92 213,675 14.95 0.0813
2018-08-10 2018-06-30 13F HALYARD HEALTH COM 40650V100 3,246,700 -174,597 -5.10 185,878 17.90 0.0741
2018-05-11 2018-03-31 13F HALYARD HEALTH COM 40650V100 3,421,297 40,934 1.21 157,653 0.99 0.0657
2018-02-12 2017-12-31 13F HALYARD HEALTH COM 40650V100 3,380,363 87,880 2.67 156,107 5.29 0.0647
2017-11-13 2017-09-30 13F HALYARD HEALTH COM 40650V100 3,292,483 159,434 5.09 148,262 20.47 0.0648
2017-08-11 2017-06-30 13F HALYARD HEALTH COM 40650V100 3,133,049 507,893 19.35 123,067 23.08 0.0568
2017-05-12 2017-03-31 13F HALYARD HEALTH COM 40650V100 2,625,156 415,105 18.78 99,992 22.35 0.0478
2017-02-09 2016-12-31 13F HALYARD HEALTH COM 40650V100 2,210,051 330,186 17.56 81,729 25.44 0.0408
2016-11-10 2016-09-30 13F HALYARD HEALTH COM 40650V100 1,879,865 339,988 22.08 65,155 30.11 0.0352
2016-08-09 2016-06-30 13F HALYARD HEALTH COM 40650V100 1,539,877 103,829 7.23 50,076 21.37 0.0288
2016-05-13 2016-03-31 13F HALYARD HEALTH COM 40650V100 1,436,048 237,032 19.77 41,259 3.00 0.0247
2016-02-10 2015-12-31 13F HALYARD HEALTH COM 40650V100 1,199,016 -85,152 -6.63 40,059 9.68 0.0250
2015-11-13 2015-09-30 13F HALYARD HEALTH COM 40650V100 1,284,168 183,206 16.64 36,522 -18.09 0.0240
2015-08-14 2015-06-30 13F HALYARD HEALTH COM 40650V100 1,100,962 691,257 168.72 44,589 121.21 0.0273
2015-05-14 2015-03-31 13F HALYARD HEALTH COM 40650V100 409,705 354,527 642.52 20,157 703.39 0.0127
2015-02-06 2014-12-31 13F HALYARD HEALTH COM 40650V100 55,178 55,178 2,509 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.